Impact of the COVID-19 pandemic on HCV elimination in Spain.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Pathway to hepatitis C elimination: insights from a large tertiary hospital in South China.Annals of medicine · 2025
   Article
2. Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.BMC infectious diseases · 2024
   Article
3. Impact of COVID-19 on epidemic trend of hepatitis C in Henan Province assessed by interrupted time series analysis.BMC infectious diseases · 2023
   Article
4. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.The Lancet. Public health · 2023
   Article
5. Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021.Frontiers in public health · 2023
   Article
6. Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention.Frontiers in public health · 2023
   Article
7. HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic.Journal of viral hepatitis · 2022
   Article
8. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.Journal of hepatology · 2022
   Article
9. Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey.JHEP reports : innovation in hepatology · 2022
   Article
10. SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis.Infection · 2022
    Review
11. Cost-effectiveness analysis of an active search to retrieve HCV patients lost to follow-up (RELINK-C strategy) and the impact of COVID-19.Journal of viral hepatitis · 2022
    Article
12. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?Journal of hepatology · 2022
    Article
13. Hepatitis C liver disease during COVID-19 pandemic in Egypt: Challenges and way forward.Ethics, medicine, and public health · 2021
    Article
14. Liver and COVID-19: From care of patients with liver diseases to liver injury.World journal of hepatology · 2021
    Review
15. HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?Journal of hepatology · 2021
    Article
16. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.Journal of hepatology · 2021
    Article
17. Hepatitis C elimination protocol in Cantabria: Updated regional strategy and outcomes from a population-based cohort and opportunistic screening programs.Sage open chronic disease
    Article

Corrections and comments

• Comment on
  Impact of COVID-19 on global HCV elimination efforts.2021

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as